Mode
Home
Conditions Medications Drug Pipeline Weekly Digests Questions
Text Size
Log in / Sign up
Home › Conditions › Blastic plasmacytoid dendritic cell neoplasm

Blastic plasmacytoid dendritic cell neoplasm

Part of Leukemia

1 published article · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Pivekimab sunirine shows activity in frontline and relapsed Blastic plasmacytoid dendritic cell neoplasm
Dermatology Phase I
Pivekimab sunirine shows activity in frontline and relapsed Blastic plasmacytoid dendritic cell neoplasm A New Drug Shows Striking Promise for a Rare and Aggressive Blood Cancer
This phase I/II single-arm trial evaluated pivekimab sunirine in adults with Blastic plasmacytoid dendritic cell neoplasm (BPDCN).
For a cancer with very few options, this therapy is changing the outlook for patients and creating a clear path to potentially curative stem…
Apr 9, 2026